Skip to content
Screener

Medpace Holdings, Inc. MEDP Q1 2025 earnings

Reported April 21, 2025 · After market close

Revenue$558.6MBeat by $32.2M
EPS$3.67Beat by $0.61
Revenue estimate$526.3M
EPS estimate$3.06

Next report

Oct 28, 2026 (in 3 months)
Revenue estimate$714.3M
EPS estimate$4.39

Financials

Q1 2025

Income statement

See full
Revenue$558.6M+9.3%
Operating income$113.5M+9.1%
Net income$114.6M+11.7%
EPS (diluted)$3.67+14.7%

Balance sheet

See full
Cash & equivalents$441.4M+8.5%
Total debt$150.3M-4.9%
Total equity$593.6M-11.6%
Total assets$1.9B+5.7%

Cash flow

See full
Operating cash flow$125.8M-17.6%
CapEx$10.0M+81.8%
Free cash flow$115.8M-21.3%

Valuation & ratios

Valuation

as of 03/31/25
See full
Market cap$9.28B-25.5%
Enterprise value$8.99B-26.4%
P/E22.3×-17.6×
P/S4.3×-2.0×

Profitability

See full
Operating margin21.2%+3.1pp
Net margin19.3%+3.4pp
FCF margin25.1%+1.0pp

Returns & leverage

See full
Return on equity65.8%+4.5pp
Debt / equity0.3×0.0×
Current ratio0.7×0.0×

Segments

By product

See full
Metabolic$170.5M+9.8%
Oncology$148.0M+42.8%
Other$95.8M-11.6%
Central Nervous System$58.3M+4.7%
Cardiology$54.9M+24.4%

By segment

See full
Reportable Segment$558.6M+9.3%

FAQ

When did Medpace Holdings, Inc. report Q1 2025 earnings?
Medpace Holdings, Inc. (MEDP) reported Q1 2025 earnings on April 21, 2025 after market close.
What were Medpace Holdings, Inc.'s Q1 2025 revenue and EPS?
Medpace Holdings, Inc. reported revenue of $558.6M and eps of $3.67 for Q1 2025.
Did Medpace Holdings, Inc. beat estimates in Q1 2025?
Revenue beat the consensus estimate of $526.3M by $32.2M. EPS beat the consensus estimate of $3.06 by $0.61.
Where can I find Medpace Holdings, Inc.'s Q1 2025 SEC filings?
You can read the 8-K earnings release (0001668397-25-000056) and the 10-Q periodic report (0001668397-25-000059) directly on SEC EDGAR. The filing index links above go to sec.gov.